EP2488192
COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR
:
EP einkaleyfi: Þýðing ekki lögð inn:
8.10.2010:
30.8.2017:
10765917.9
:
7.10.2030
:
COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR
8.10.2010
30.8.2017
:
Bristol-Myers Squibb Holdings Ireland:
Hinterbergstrasse 16, 6312, Steinhausen, CH
:
LEMM, Julie A.:
Wallingford, Connecticut, US
:
VOSS, Stacey A.:
Wallingford, Connecticut, US
:
GAO, Min:
Wallingford, Connecticut, US
:
CHANIEWSKI, Susan E.:
Wallingford, Connecticut, US
:
SHEAFFER, Amy K.:
Wallingford, Connecticut, US
:
MCPHEE, Fiona:
Wallingford, Connecticut, US
:
250648 P:
12.10.2009:
US
:
899840:
7.10.2010:
US
:
US2010051898:
8.10.2010
:
A61K 38/06, A61K 45/06, A61K 31/4178, A61P 31/12